Moeten innovaties in een RCT geëvalueerd worden? Overwegingen bij de selectie van patiënten voor protonentherapie

Translated title of the contribution: Should every innovation be evaluated in a randomized controlled trial (RCT)? Considerations for the selection of patients for proton therapy

Dirk de Ruysscher, Liesbeth J. Boersma*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Translated title of the contributionShould every innovation be evaluated in a randomized controlled trial (RCT)? Considerations for the selection of patients for proton therapy
Original languageDutch
Article numberD6085
JournalNederlands Tijdschrift voor Geneeskunde
Volume165
Issue number30
Publication statusPublished - 30 Jul 2021

Cite this